Editorial: Pregnancy and rheumatoid arthritis-do not let the perfect become the enemy of the good

Current Opinion in Rheumatology

Volumn 26, Issue 3, 2014, Pages 299-301

  Cush, John J ^a   Kavanaugh, Arthur ^b  

^a BAYLOR RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT;

CHILDBIRTH; DISEASE ACTIVITY; DRUG SAFETY; EDITORIAL; ENVIRONMENTAL EXPOSURE; FETUS DEVELOPMENT; FETUS OUTCOME; HUMAN; OBSTETRICIAN; PATIENT DECISION MAKING; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT INDICATION; TREATMENT OUTCOME; ARTHRITIS, RHEUMATOID; FEMALE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84897481771     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000061     Document Type: Editorial

References (5)

1. Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006; 54:899-907.
2. Reed SD, Vollan TA, Svec M.A. Pregnancy outcomes in women with rheumatoid arthritis in Washington State. Matern Child Health J 2006; 10:361-366.
3. Kuriya B, Hernández-Díaz S, Liu J, et al. Patterns of medication use during pregnancy in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011; 63:721-728.
4. De Man YA, Dolhain RJ, van de Geijn FE, et al. Arthritis Rheum 2008; 59:1241-1248.
5. Wolfe F, Michaud K. Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choices. Arthritis Rheum 2007; 56:2135-2142.